Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Non-cash Items: 2016-2024

Historic Non-cash Items for Rocket Pharmaceuticals (RCKT) over the last 9 years, with Dec 2024 value amounting to $63.3 million.

  • Rocket Pharmaceuticals' Non-cash Items fell 90.51% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year decrease of 90.51%. This contributed to the annual value of $63.3 million for FY2024, which is 74.74% down from last year.
  • Rocket Pharmaceuticals' Non-cash Items amounted to $63.3 million in FY2024, which was down 74.74% from $250.6 million recorded in FY2023.
  • In the past 5 years, Rocket Pharmaceuticals' Non-cash Items registered a high of $504.1 million during FY2020, and its lowest value of $63.3 million during FY2024.
  • For the 3-year period, Rocket Pharmaceuticals' Non-cash Items averaged around $144.2 million, with its median value being $118.8 million (2022).
  • As far as peak fluctuations go, Rocket Pharmaceuticals' Non-cash Items spiked by 207.33% in 2020, and later tumbled by 74.74% in 2024.
  • Yearly analysis of 5 years shows Rocket Pharmaceuticals' Non-cash Items stood at $504.1 million in 2020, then slumped by 74.45% to $128.8 million in 2021, then declined by 7.80% to $118.8 million in 2022, then soared by 111.00% to $250.6 million in 2023, then crashed by 74.74% to $63.3 million in 2024.